Cargando…

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events

Each injection of any known vaccine results in a strong expression of pro-inflammatory cytokines. This is the result of the innate immune system activation, without which no adaptive response to the injection of vaccines is possible. Unfortunately, the degree of inflammation produced by COVID-19 mRN...

Descripción completa

Detalles Bibliográficos
Autores principales: Giannotta, Girolamo, Murrone, Antonio, Giannotta, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145134/
https://www.ncbi.nlm.nih.gov/pubmed/37112659
http://dx.doi.org/10.3390/vaccines11040747
_version_ 1785034260284964864
author Giannotta, Girolamo
Murrone, Antonio
Giannotta, Nicola
author_facet Giannotta, Girolamo
Murrone, Antonio
Giannotta, Nicola
author_sort Giannotta, Girolamo
collection PubMed
description Each injection of any known vaccine results in a strong expression of pro-inflammatory cytokines. This is the result of the innate immune system activation, without which no adaptive response to the injection of vaccines is possible. Unfortunately, the degree of inflammation produced by COVID-19 mRNA vaccines is variable, probably depending on genetic background and previous immune experiences, which through epigenetic modifications could have made the innate immune system of each individual tolerant or reactive to subsequent immune stimulations.We hypothesize that we can move from a limited pro-inflammatory condition to conditions of increasing expression of pro-inflammatory cytokines that can culminate in multisystem hyperinflammatory syndromes following COVID-19 mRNA vaccines (MIS-V). We have graphically represented this idea in a hypothetical inflammatory pyramid (IP) and we have correlated the time factor to the degree of inflammation produced after the injection of vaccines. Furthermore, we have placed the clinical manifestations within this hypothetical IP, correlating them to the degree of inflammation produced. Surprisingly, excluding the possible presence of an early MIS-V, the time factor and the complexity of clinical manifestations are correlated to the increasing degree of inflammation: symptoms, heart disease and syndromes (MIS-V).
format Online
Article
Text
id pubmed-10145134
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101451342023-04-29 COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events Giannotta, Girolamo Murrone, Antonio Giannotta, Nicola Vaccines (Basel) Review Each injection of any known vaccine results in a strong expression of pro-inflammatory cytokines. This is the result of the innate immune system activation, without which no adaptive response to the injection of vaccines is possible. Unfortunately, the degree of inflammation produced by COVID-19 mRNA vaccines is variable, probably depending on genetic background and previous immune experiences, which through epigenetic modifications could have made the innate immune system of each individual tolerant or reactive to subsequent immune stimulations.We hypothesize that we can move from a limited pro-inflammatory condition to conditions of increasing expression of pro-inflammatory cytokines that can culminate in multisystem hyperinflammatory syndromes following COVID-19 mRNA vaccines (MIS-V). We have graphically represented this idea in a hypothetical inflammatory pyramid (IP) and we have correlated the time factor to the degree of inflammation produced after the injection of vaccines. Furthermore, we have placed the clinical manifestations within this hypothetical IP, correlating them to the degree of inflammation produced. Surprisingly, excluding the possible presence of an early MIS-V, the time factor and the complexity of clinical manifestations are correlated to the increasing degree of inflammation: symptoms, heart disease and syndromes (MIS-V). MDPI 2023-03-28 /pmc/articles/PMC10145134/ /pubmed/37112659 http://dx.doi.org/10.3390/vaccines11040747 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Giannotta, Girolamo
Murrone, Antonio
Giannotta, Nicola
COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
title COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
title_full COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
title_fullStr COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
title_full_unstemmed COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
title_short COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
title_sort covid-19 mrna vaccines: the molecular basis of some adverse events
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145134/
https://www.ncbi.nlm.nih.gov/pubmed/37112659
http://dx.doi.org/10.3390/vaccines11040747
work_keys_str_mv AT giannottagirolamo covid19mrnavaccinesthemolecularbasisofsomeadverseevents
AT murroneantonio covid19mrnavaccinesthemolecularbasisofsomeadverseevents
AT giannottanicola covid19mrnavaccinesthemolecularbasisofsomeadverseevents